{
    "clinical_study": {
        "@rank": "149559", 
        "acronym": "ReSET-2", 
        "arm_group": [
            {
                "arm_group_label": "Renal denervation by ablation of the renal arteries", 
                "arm_group_type": "Active Comparator", 
                "description": "By femoral access, renal angiography is performed. The patient will be sedated. In case of acceptable renal artery anatomy allowing renal ablation, the patient will be randomized in the cath. lab. If randomized to active treatment, renal artery ablation will be carried out straight away."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Sham Comparator", 
                "description": "By femoral access, renal angiography is performed. The patient will be sedated. In case of acceptable renal artery anatomy allowing renal ablation, the patient will be randomized in the cath. lab. If randomized to sham treatment, the procedure stops."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this double-blind, randomized and sham controlled study is to investigate the\n      blood pressure lowering effect of renal denervation by catheter based ablation in the renal\n      arteries in patients with milder forms of treatment resistant hypertension. The effect on\n      blood pressure will be evaluated by 24-hour ambulatory blood pressure measurements at\n      baseline and after 3 and 6 months of follow up. Secondary endpoint evaluation comprises\n      hemodynamic assessment by applanation tonometry and the cold pressor response."
        }, 
        "brief_title": "Renal Denervation in Treatment Resistant Hypertension", 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Systolic daytime (24 hour-ambulatory blood pressure measurement) > 135 mmHg and < 145\n             mmHg.\n\n          -  Stable (for at least 1 month and with no planned changes for the next 6 months)\n             antihypertensive therapy with at least 3 antihypertensive drugs, including a\n             diuretic.\n\n          -  Documented adherence to present antihypertensive therapy\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Non compliance\n\n          -  Heart failure (NYHA Class III-IV)\n\n          -  LV ejection fraction < 50 %\n\n          -  Renal insufficiency (eGFR<30 ml/min)\n\n          -  Unstable coronary heart disease\n\n          -  Coronary intervention within 6 months\n\n          -  Myocardial infarction within 6 months\n\n          -  Claudication\n\n          -  Orthostatic syncope within 6 months\n\n          -  Secondary hypertension (except CKD)\n\n          -  Significant valvular heart disease\n\n          -  Clinically significant biochemical abnormalities (electrolytes, haemoglobin, hepatic\n             function, thyroid)\n\n          -  Second and third degree AV block\n\n          -  Macroscopic haematuria\n\n          -  Renal artery anatomy not suitable for renal artery ablation (Stenosis, diameter < 4\n             mm, length < 2 cm or severe calcifications)\n\n          -  Moderate/severe obstructive sleep apnoea (AHI > 15) if CPAP treatment has not been\n             attempted"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762488", 
            "org_study_id": "35218"
        }, 
        "intervention": [
            {
                "arm_group_label": "Renal denervation by ablation of the renal arteries", 
                "description": "Catheter-based renal denervation by applying low power radiofrequency to the renal artery using the EnligHTN Catheter, introduced by femoral artery access.", 
                "intervention_name": "Ablation of the renal arteries", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Renal angiography by femoral access", 
                "intervention_name": "Renal angiography", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Treatment Resistant Hypertension", 
            "Renal Denervation"
        ], 
        "lastchanged_date": "January 5, 2013", 
        "location": {
            "contact": {
                "email": "henvas@rm.dk", 
                "last_name": "Henrik Vase, MD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8200"
                }, 
                "name": "Aarhus University Hospital, Skejby"
            }, 
            "investigator": {
                "last_name": "Henrik Vase, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Renal Denervation in Treatment Resistant Hypertension, a Double-blind Randomized Controlled Trial", 
        "overall_contact": {
            "email": "henvas@rm.dk", 
            "last_name": "Henrik Vase, MD, PhD"
        }, 
        "overall_contact_backup": {
            "email": "onm@farm.au.dk", 
            "last_name": "Ole Mathiassen, MD, PhD"
        }, 
        "overall_official": {
            "affiliation": "Skejby Hospital, Dept. of Cardiology", 
            "last_name": "Henrik Vase, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Ethics Committee", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in daytime systolic blood pressure (24-hour ambulatory blood pressure measurement)", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762488"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Skejby Hospital", 
            "investigator_full_name": "Henrik Vase", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in blood pressure (clinic and 24-hour ambulatory blood pressure measurement)", 
                "safety_issue": "No", 
                "time_frame": "3 and 6 months"
            }, 
            {
                "measure": "Change from baseline in central blood pressure, augmentation index and pulse wave velocity", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Change from baseline in cold pressor response", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Change from baseline in intensity of medical antihypertensive therapy", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months"
            }, 
            {
                "measure": "Blood pressure (clinic measurement)", 
                "safety_issue": "Yes", 
                "time_frame": "1, 3 and 6 months"
            }, 
            {
                "measure": "Renal function (eGFR and electrolytes)", 
                "safety_issue": "Yes", 
                "time_frame": "1, 3 and 6 months"
            }
        ], 
        "source": "Aarhus University Hospital Skejby", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Aarhus University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Regionshospitalet Silkeborg", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Randers Regional Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Viborg Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Regional Hospital Holstebro", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Henrik Vase", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}